Immunotherapeutic treatment of inflammation in mice exposed to methamphetamine

Immunotherapeutic treatment of inflammation in mice exposed to methamphetamine

IntroductionCurrently, there are no FDA-approved medications to treat methamphetamine addiction, including the inflammatory, neurotoxic, and adverse neuropsychiatric effects. We have shown that partial (p)MHC class II constructs (i.e., Recombinant T-cell receptor Ligand – RTL1000), comprised of the...

Full description

Bibliographic Details
Main Authors: Jennifer M. Loftis, Sankrith Ramani, Evan J. Firsick, Rebekah Hudson, Anh Le-Cook, Kevin S. Murnane, Arthur Vandenbark, Renee L. Shirley
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Psychiatry
Subjects:
addiction
chemokine
drug discovery
frontal cortex
inflammation
methamphetamine
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1259041/full

Internet

https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1259041/full

Similar Items